Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Disparities in survival after trimodality therapy for esophageal adenocarcinoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Disparities in survival after trimodality therapy for esophageal adenocarcinoma.
Disparities in survival after trimodality therapy for esophageal adenocarcinoma. Dis Esophagus. 2018 Sep 01; 31(9).
View in:
PubMed
subject areas
Adenocarcinoma
Aged
Antineoplastic Protocols
Chemoradiotherapy, Adjuvant
Combined Modality Therapy
Esophageal Neoplasms
Esophagectomy
Female
Health Services Accessibility
Healthcare Disparities
Humans
Male
Middle Aged
Multivariate Analysis
Neoadjuvant Therapy
Proportional Hazards Models
Regression Analysis
Retrospective Studies